Skip to search boxSkip to navigationSkip to main content

RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21

  • Tae Jin Lee
    ,
  • Ji Young Yoo
    ,
  • Dan Shu
    ,
  • Hui Li
    ,
  • Jianying Zhang
    ,
  • Jun Ge Yu
*Corresponding author for this work
  • Ohio State University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

Targeted inhibition of oncogenic miRNA-21 has been proposed to treat glioblastoma by rescuing tumor suppressors, PTEN and PDCD4. However, systemic delivery of anti-miR-21 sequences requires a robust and efficient delivery platform to successfully inhibit this druggable target. Three-way-junction (3WJ)-based RNA nanoparticles (RNP), artificially derived from pRNA of bacteriophage phi29 DNA packaging motor, was recently shown to target glioblastoma. Here, we report that multi-valent folate (FA)-conjugated 3WJ RNP constructed to harbor anti-miR-21 LNA sequences (FA-3WJ-LNA-miR21) specifically targeted and delivered anti-miR-21 LNA and knocked down miR-21 expression in glioblastoma cells in vitro and in vivo with favorable biodistribution. Systemically injected FA-3WJ-LNA-miR21 RNP efficiently rescued PTEN and PDCD4, resulting in glioblastoma cell apoptosis and tumor growth regression. Overall survival rate was also significantly improved by FA-3WJ-LNA-miR21 RNP. These results are indicative of the clinical benefit of FA-3WJ RNP-based gene therapy for the successful targeted therapy of developing and even recurring glioblastoma.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1544-1555 (12 pages)

Journal (Volume, Issue Number)

Molecular Therapy (Volume 25, Issue 7)

Publication milestones

  • Published - 07/05/2017

Publication status

Published - 07/05/2017

ISSN

1525-0016

Publication IDs

  • Scopus: 85021814028
  • PubMed: 28109960

Publication metrics

Metrics

Fractional count
1
Fractional count
0.06
Fractional count
15
Fractional count
0.94
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
137
Citation count
135

Funding Details

We thank Dr. Anna Bratasz at the Small Animal Imaging Core (SAIC) of the Ohio State University for MRI imaging of mice and Dr. Sara Cole at the Campus Microscope & Immunology Facility (CMIF) of the Ohio State University Medical Center for live cell confocal microscopy imaging. We also thank Drs. Dorothee Wernicke-Jameson and Nicola Zanesi for their assistance in animal care. The current research was supported by NIH grants R35CA197706 (C.M.C.), U01CA151648 (P.G.), R01CA186100 (P.G.), R01NS064607 (B.K.), R01CA150153 (B.K.), P01CA163205 (B.K.), P30CA16058 (B.K. in part), and IRG-67-003-50 (J.Y.Y.), CA186542-01A1 (A.C.J.-R.), DOD grant W81XWH-15-1-0052 (D.S.), and FACS by CCSG grant P30CA016058.
FundersFunding numbers
CCSG
P30CA016058
FACS Laboratory
-
Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center
-
NIH
P01CA163205, U01CA151648, IRG-67-003-50, P30CA16058, R01CA150153, R01CA186100, R35CA197706, CA186542-01A1, R01NS064607
DOD
W81XWH-15-1-0052
NIGMS
R01GM114080
OSU
-